TAL
JAZZ icon

TIG Advisors LLC’s Jazz Pharmaceuticals JAZZ Stock Holding History

TIG Advisors LLC’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-27,431
Closed -$4.51M – 413
2021
Q1 		$4.51M Buy
+27,431
New +$4.51M 0.17% 117

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TIG Advisors LLC's JAZZ Position: Q2 2021 in Review

TIG Advisors LLC sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2021, closing a stake of 27,431 shares — an estimated $4.51M sold.

TIG Advisors LLC first reported a position in JAZZ in Q1 2021 and held it in 1 quarter. The position peaked at $4.51M in Q1 2021. 505 funds tracked by Wall St. Rank hold JAZZ as of Q2 2021.

  • TIG Advisors LLC reported no remaining Jazz Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • TIG Advisors LLC sold 27,431 Jazz Pharmaceuticals shares in Q2 2021, an estimated $4.51M.
  • TIG Advisors LLC first reported a position in Jazz Pharmaceuticals in Q1 2021 and held it in 1 quarter.
  • TIG Advisors LLC's Jazz Pharmaceuticals position peaked at $4.51M in Q1 2021.
  • 505 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2021.

Based on TIG Advisors LLC's 13F filing for Q2 2021, filed 16 Aug 2021.